It is our pleasure to announce that Nielka van Erp and Roger Brüggemann have been appointed as associated professor.Nielka's research is embedded within the research theme Urological cancers and lies in the field of the pharmacology of targeted oncolytics and the use of pharmacology to individualize and optimize cancer treatment.
Roger’s research focuses on clinical pharmacology of anti-infectives in special patient populations with a focus on antifungal agents. His research takes place within the research theme Infectious diseases and global health.
Van Erp and Brüggemann were both appointed associated professor per 1 July 2018. We wish them a successful continuation of their career in the Radboudumc.
Related news items
3D breast ultrasound elastography to improve breast cancer detection5 November 2019
One out of seven women will be diagnosed with breast cancer during their life. Early detection of breast cancer is important to increase the survival rate. Gijs Hendriks graduated recently on a new technique, 3D elastography, to detect breast cancer better.read more
Radboudumc and Quirem Medical sign cooperation agreement31 October 2019
Radboudumc and Quirem Medical signed an agreement for joint research. The agreement includes several existing and future projects based on small radioactive spheres. Enhanced cooperation should improve the treatment of cancer patients and stimulate research into new applications.read more
Euthanasia requests in dementia cases what are experiences and needs of Dutch physicians?31 October 2019
In BMC Medical Ethics Jaap Schuurmans, Yvonne Engels et al described the results of a study in which general practitioners and elderly care physicians were interviewed about their experiences and support needs when confronted with a euthanasia request of a person with dementia.read more